This difference in molecular design likely contributes to the consistently superior outcomes seen with semaglutide across clinical trials, particularly for weight loss and HbA1c reduction
Abnormal IGF-1 and GH levels have been proposed to play a key role in obesity [130, 240, 241]
The KIT gene controls mast cell creation from stem cells in the bone marrow, and mutations in KIT cause excess mast cell proliferation.[ref][ref] A mastocytosis diagnosis is either systemic mastocytosis (affecting the whole body) or cutaneous mastocytosis, which has more skin-related symptoms
The semaglutide group had a 24% lower risk for the composite primary endpoint compared with the placebo group
Another similar platform, OpenLoop Health, offers the same service
In these cases, elevated B12 is not the cause but a marker prompting further investigation